1. Home
  2. OSRH vs ALUR Comparison

OSRH vs ALUR Comparison

Compare OSRH & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OSR Holdings Inc.

OSRH

OSR Holdings Inc.

HOLD

Current Price

$0.52

Market Cap

18.4M

Sector

N/A

ML Signal

HOLD

ALUR

Allurion Technologies Inc.

HOLD

Current Price

$1.12

Market Cap

18.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSRH
ALUR
Founded
N/A
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
18.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OSRH
ALUR
Price
$0.52
$1.12
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$9.25
AVG Volume (30 Days)
3.1M
110.4K
Earning Date
04-22-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$17,208,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$15.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$0.95
52 Week High
$11.30
$5.94

Technical Indicators

Market Signals
Indicator
OSRH
ALUR
Relative Strength Index (RSI) 39.46 37.79
Support Level $0.49 $1.04
Resistance Level $0.58 $1.41
Average True Range (ATR) 0.08 0.17
MACD -0.02 -0.04
Stochastic Oscillator 8.84 24.64

Price Performance

Historical Comparison
OSRH
ALUR

About OSRH OSR Holdings Inc.

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Share on Social Networks: